Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative, first-in-class medicines, has announced its participation in the 2024 Cantor Global Healthcare Conference. Justin Renz, the company's Chief Financial and Operations Officer, will engage in a fireside chat on Thursday, September 19, 2024, at 9:10 A.M. Eastern Time in New York City.
Interested parties can access a live webcast of the panel presentation through the Events and Presentations page on the Ardelyx website. For those unable to attend, a replay of the fireside chat will be available on the company's website for 30 days following the event, providing an opportunity for investors and stakeholders to gain insights into Ardelyx's operations and future plans.
Ardelyx, Inc. (Nasdaq: ARDX), un'azienda biofarmaceutica focalizzata sullo sviluppo di medicinali innovativi e di prima classe, ha annunciato la sua partecipazione alla Conferenza Sanitaria Globale Cantor 2024. Justin Renz, il Chief Financial and Operations Officer dell'azienda, parteciperà a un fireside chat giovedì 19 settembre 2024, alle 9:10 A.M. Eastern Time a New York City.
Le parti interessate possono accedere a un webcast dal vivo della presentazione del panel attraverso la pagina Eventi e Presentazioni del sito web di Ardelyx. Per coloro che non possono partecipare, sarà disponibile un ripasso del fireside chat sul sito web dell'azienda per 30 giorni dopo l'evento, offrendo un'opportunità agli investitori e agli stakeholder di ottenere informazioni sulle operazioni e i piani futuri di Ardelyx.
Ardelyx, Inc. (Nasdaq: ARDX), una empresa biofarmacéutica centrada en el desarrollo de medicamentos innovadores y de primera clase, ha anunciado su participación en la Conferencia Global de Salud Cantor 2024. Justin Renz, el Director Financiero y de Operaciones de la empresa, participará en una charla en la fogata el jueves 19 de septiembre de 2024, a las 9:10 A.M. Eastern Time en la ciudad de Nueva York.
Las partes interesadas pueden acceder a una transmisión en vivo de la presentación del panel a través de la página de Eventos y Presentaciones en el sito web de Ardelyx. Para aquellos que no puedan asistir, habrá un repetición de la charla en la fogata disponible en el sitio web de la empresa por 30 días después del evento, brindando una oportunidad para que los inversionistas y las partes interesadas obtengan información sobre las operaciones y los planes futuros de Ardelyx.
Ardelyx, Inc. (Nasdaq: ARDX)는 혁신적이고 첫 번째 클래스의 의약품 개발에 집중하는 생명공학 회사로, 2024 칸토 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 최고 재무 및 운영 책임자인 Justin Renz는 2024년 9월 19일 목요일 동부 표준시 기준 오전 9시 10분에 뉴욕에서 파이어사이드 챗에 참여할 예정입니다.
관심 있는 당사자는 Ardelyx 웹사이트의 이벤트 및 발표 페이지를 통해 패널 발표의 실시간 웹캐스트에 접근할 수 있습니다. 참석할 수 없는 분들을 위해, 이벤트 후 30일 간 회사 웹사이트에서 파이어사이드 챗의 재방송이 제공되어 Ardelyx의 운영 및 향후 계획에 대한 통찰력을 얻을 수 있는 기회를 제공합니다.
Ardelyx, Inc. (Nasdaq: ARDX), une entreprise biopharmaceutique axée sur le développement de médicaments innovants et de première classe, a annoncé sa participation à la Conférence mondiale sur la santé Cantor 2024. Justin Renz, le directeur financier et des opérations de l'entreprise, participera à une discussion informelle jeudi 19 septembre 2024, à 9h10 heure de l'Est à New York.
Les parties intéressées peuvent accéder à un webcast en direct de la présentation du panel via la page Événements et Présentations sur le site web d'Ardelyx. Pour ceux qui ne peuvent pas assister, une rediffusion de la discussion informelle sera disponible sur le site de l'entreprise pendant 30 jours après l'événement, offrant aux investisseurs et aux parties prenantes l'occasion d'obtenir des informations sur les opérations et les plans futurs d'Ardelyx.
Ardelyx, Inc. (Nasdaq: ARDX), ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung innovativer, erstklassiger Medikamente konzentriert, hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference angekündigt. Justin Renz, der Chief Financial and Operations Officer des Unternehmens, wird am Donnerstag, den 19. September 2024, um 9:10 Uhr Eastern Time in New York City an einem Fireside Chat teilnehmen.
Interessierte Parteien können über die Seite Veranstaltungen und Präsentationen auf der Ardelyx-Website auf ein Live-Webcast der Podiumsdiskussion zugreifen. Für diejenigen, die nicht teilnehmen können, wird eine Wiederholung des Fireside Chats auf der Unternehmenswebsite für 30 Tage nach der Veranstaltung verfügbar sein, um den Investoren und Stakeholdern die Möglichkeit zu geben, Einblicke in die Arbeitsweise und zukünftige Pläne von Ardelyx zu erhalten.
- None.
- None.
WALTHAM, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Justin Renz, Chief Financial and Operations Officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 9:10 A.M. Eastern Time in New York City.
To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations. A replay of the fireside chat will be available on the Ardelyx website for 30 days following the event.
About Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.
Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com
FAQ
When is Ardelyx (ARDX) participating in the 2024 Cantor Global Healthcare Conference?
Who will represent Ardelyx (ARDX) at the 2024 Cantor Global Healthcare Conference?
How can I access the live webcast of Ardelyx's (ARDX) presentation at the 2024 Cantor Global Healthcare Conference?
How long will the replay of Ardelyx's (ARDX) fireside chat be available on their website?
